NCT02271334View on ClinicalTrials.gov

Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2015

Conditions
Asthma
Interventions
DRUG

A006 DPI

Single dose 110 mcg, 1 inhalation

DRUG

A006 DPI

Single dose 220 mcg, 1 inhalation

DRUG

Proventil® MDI

Single dose 90 mcg, 1 inhalation

DRUG

Proventil® MDI

Single dose 90 mcg, 2 inhalations

Trial Locations (1)

90630

Amphastar Site 0035, Cypress

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY